FarmPharma AB (publ), which is a subsidiary of Double Bond Pharmaceutical International AB (publ), has today reported that the second recombinant bovine interferon, which is the second component of FarmPharma’s product InterferOX, has been manufactured.
“The development of antiviral agents with innovative mechanisms of action is becoming more and more relevant,” comments Igor Lokot, SO at FarmPharma. ”
The first interferon was manufactured in March 2020: link
According to the plan, InterferOX will consist of 3-5 different types of interferon.